Two Preventive Treatments Against Bronchialitis in Infants Soon to Be Better Reimbursed
6 Articles
6 Articles
The rate of reimbursement for the Beyfortus and the Abrysvo will be increased from 30 to 65% at the end of August, following a reassessment by the High Health Authority in July. The institution had then granted them a "medical service rendered important" against "moderate" until then. - Two preventive treatments against the bronchiolite of infants soon to be better reimbursed (Health and well-being).
Two preventive treatments against bronchiolite, an infection that particularly affects infants, will be better taken care of by the Social Security. According to two notices published in the Official Journal on Friday 21 August, the Beyfortus will be reimbursed 65% as from 31 August, the Abrysvo from 1 September.
Le Télégramme
France24Two major preventive treatments are better reimbursed by the end of August. Health Insurance increases the coverage to 65% for Abrysvo and Beyfortus, protecting infants from VRS.
Sickness insurance coverage for respiratory syncytial virus treatments increased from 30% to 65% at the end of August The rate of reimbursement for treatment
The rate of reimbursement of preventive treatments available against infant bronchialitis will be increased from the end of August to 65%, compared with 30% so far, according to opinions published Friday in the Official Journal.
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
